SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009690
Filing Date
2016-11-08
Accepted
2016-11-08 16:37:10
Documents
45
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20160930x10q.htm 10-Q 984747
2 EX-10.1 mrns-20160930ex1010f7eba.htm EX-10.1 110237
3 EX-31.1 mrns-20160930ex3115ae87e.htm EX-31.1 15234
4 EX-31.2 mrns-20160930ex31246e913.htm EX-31.2 15377
5 EX-32.1 mrns-20160930ex3210d400b.htm EX-32.1 9474
6 GRAPHIC mrns20160930x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-16-009690.txt   2975080

Data Files

Seq Description Document Type Size
7 EX-101.INS mrns-20160930.xml EX-101.INS 432211
8 EX-101.SCH mrns-20160930.xsd EX-101.SCH 18726
9 EX-101.CAL mrns-20160930_cal.xml EX-101.CAL 26296
10 EX-101.DEF mrns-20160930_def.xml EX-101.DEF 67249
11 EX-101.LAB mrns-20160930_lab.xml EX-101.LAB 217653
12 EX-101.PRE mrns-20160930_pre.xml EX-101.PRE 146788
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 161981716
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences